Deal Snapshot
RISKMETRICS ADVISES LSR STOCKHOLDERS TO ACCEPT LION MERGER´S OFFER
Monday 09 November 2009

US pre-clinical and non-clinical testing services provider Life Sciences Research (NYSE:LSR) said that risk manager RiskMetrics (NYSE:RMG) has advised stockholders to vote in favour of LSR´s acquisition by Lion Merger Corp.








TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 09/11/2009
Target: Life Sciences Research Inc
Country: USA
Sales: 242.42m (USD)
Sector: Healthcare
Type: MBO
Financing: Cash & Debt
Status: Agreed
Buyer: Lion Merger Corp
Vendor Advisor: RiskMetrics Group Inc
EBITDA: 46.57m (USD)
Debt: 74.13m (USD)
Debt/EBITDA: 1.59
EV/EBIT: 4.26
EV/EBITDA: 3.28
EV/Sales: 0.63
EV: 152.9m (USD)
Comment:
Advisor recommends to shareholders to vote in favour.

Options